Skip to content

Stellate Ganglion Block for Prevention of Post Mastectomy Depression

Preemptive Efficacy of Stellate Ganglion Block for Prevention of Post Mastectomy Depression

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06263907
Acronym
SGB
Enrollment
140
Registered
2024-02-16
Start date
2024-03-01
Completion date
2028-12-30
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastectomy, Pain, Acute, Pain, Chronic

Brief summary

Complications after mastectomy include chronic pain and depression.

Detailed description

A mastectomy is surgery could be associated with complications include chronic pain and depression. In female breast cancer patients, the incidence of postoperative depression was 46.55%. Stellate ganglion block had been used for treating post-traumatic stress disorder (PTSD) and depression symptoms even in its prevention. Also, it used in treatment of chronic pain.

Interventions

PROCEDUREStellate gangalion block

The efficacy of Preoperative ipsilateral stellate gangalion block on the occurrence of postmastectomy depression and pain compared with no block

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

The anesthesiologist, who will be responsible for opening the envelope and do the block or not according to the group besides, evaluation of its success and covering the skin over the site of ipsilateral stellate gangalion with sterile dressing in both groups, will not be involved in data collection.

Intervention model description

Patients will be randomization into two equal groups using computer-generated random numbers prior to surgery of 70 each; Group S: will receive ipsilateral stellate gangalion block and Group C: will receive no block.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female patients * Age ranging from 18 to 65 years * American Society of Anesthesiologists (ASA) no more than II * Had unilateral cancer breast * Scheduled to do unilateral modified radical mastectomy

Exclusion criteria

* Pregnant female * Existing Horner syndrome * Had any neuromuscular disease * Had allergy to local anesthetics * History of use of analgesics * Had any deformity or a previous surgery in the neck or ipsilateral arm or breast * Had any contraindication to the procedure (coagulation disorders, local infection, sepsis) * Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders) * History of psychotic disorder including depression, bipolar disorder or personality disorder * Patient with Beck Depression Inventory (BDI) score more than 13

Design outcomes

Primary

MeasureTime frameDescription
incidence of postmastectomy depression6 months postoperativelyBeck Depression Inventory (BDI) score

Secondary

MeasureTime frameDescription
incidence of postmastectomy depression3 months postoperativelyBeck Depression Inventory (BDI) score
the need for postoperative antidepressantduring the first 6 months postoperativelyneeded or not
acute postoperative pain at the incision site (breast and the axilla)every 12 hour for the first 48 hour recordedNumerical rating scale (NRS) (0-10)
chronic postmastectomy pain at the incision siteat 3 and 6 months postoperativelyNumerical rating scale (NRS) (0-10)
incidence of nausea and vomitingduring first 3 postoperative daysoccurred or not
Functional pain in the ipsilateral shoulderduring the first 6 months postoperativelyextended from the shoulder to the elbow or to the hand either associated with swelling, changing in the colour or temperature of that limb or associated with reduction in the range of the movement (elbow extension or arm abduction or fixed flexion deformity
Any complications related to stellate ganglion injectionwithin 1 day postoperativelylocal hematoma, persistent postoperative horner's syndrome or respiratory distress

Countries

Egypt

Contacts

CONTACTMaha Abo-Zeid, MD
mahazed@mans.edu.eg01019216192

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026